|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A double-blind, randomized,incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers显示文摘 | Martin PD Warwick MJ Dane AL | 2003 | Clin Ther2003，25，8： | 1 |
| 2 | Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers显示文摘 | Martin PD Warwick MJ Dane AL | 2003 | Clin Ther2003，25，10： | 1 |
| 3 | The effect of erythromycin on the pharmacokinetics of rosuvastatin 显示文摘 | Cooper KJ Martin PD Dane AL | 2003 | Eur J Clin Pharmacol2003，59，1： | 1 |
| 4 | Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects显示文摘 | Cooper KJ Martin PD Dane AL | 2003 | BrJ Clin Pharmacol2003，55，1： | 1 |
| 5 | The effect of fluconazole on the pharmacokinetics of rosuvastatin显示文摘 | Cooper KJ Martin PD Dane AL | 2002 | Eur J Clin Pharmacol2002，58，8： | 1 |
| 6 | Effect of itraconazole on the pharmacokinetics of rosuvastatin显示文摘 | Cooper K J Martin PD Dane AL | 2003 | Clin Pharmacol Ther2003，73，4： | 1 |
| 7 | Single-and multiple-dose pharmacokinetics and safety of the new HMGCoA reductase inhibitor ZD4522显示文摘 | Warwick MJ Dane AL Raza A | 2000 | Atherosclerosis2000，151，1： | 1 |
| 8 | A double-blind, randomized, incomplete crossover, trial to assess the dose propor- tionality of rosuvastatin in healthy volunteers 显示文摘 | Martin PD Warwick MJ Dane AL | 2003 | Clin Ther2003，25，8： | 1 |
| 9 | A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers显示文摘 | Martin PD Warwick MJ Dane AL | 2003 | Clin Ther2003，25，8： | 1 |
| 10 | Effect of itraconazole on the pharmacokinetics of rosuvastatin显示文摘 | Cooper KJ Martin PD Dane AL | 2003 | Clin Pharmacol Ther2003，73，4： | 1 |
| 11 | Effect of itraconazole on the pharmacokinetics of rosuvastatin显示文摘 | COOPER KJ MARTIN PD DANE AL | 2003 | Clin Pharmacol Ther2003，73，4： | 1 |
| 12 | The effect of fluconazole on the pharmacokinetics of rosuvastatin显示文摘 | COOPER KJ MARTIN PD DANE AL | 2002 | Eur J Clin Pharmacol2002，58，8： | 1 |
| 13 | Single-and mutiple-dose pharmacokinetics and safety of the new HMG-CoA reductase inhibitor ZD4522显示文摘 | Warwick MJ Dane AL Raza A | 2000 | Atherosclerosis2000，，： | 1 |
| 14 | No effect of age and gender on the pharmacokinetics of rosuvastatin:a new HMG-COA retuctase inhibitor显示文摘 | Martin PD Dane AL Nwose D | 2002 | J Clin Pharmcol2002，42，10： | 1 |
| 15 | A double-blind,randomized,incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers显示文摘 | Martin PD Warwick MJ Dane AL | 2003 | Clin Ther2003，25，： | 1 |
| 16 | Solid-state heat-capacity lascrs:good candidates for the marketplace显示文摘 | ROTTER M D DANE C B FOCHS S et aL | 2004 | Plaotonics Spectra2004，38，8： | 1 |
| 17 | No effect of age or gender on the pharmacokinetics of rosuvastatin:a new HMG-CoA reductase inhibitor显示文摘 | Martin PD Dane AL Nwose OM | 2002 | J Clin Pharm2002，42，10： | 1 |
| 18 | Effect of itraconazole on the pharmacokinetics of rosuvastatin显示文摘 | Cooper KJ Martin PD Dane AL | 2003 | Clin Pharmacol Ther2003，73，： | 1 |
| 19 | Metabolism,excretion,and pharmacokinetics of rosuvastatin in healthy adult male volunteers显示文摘 | Martin PD Warwick MJ Dane AL | 2003 | Clin Ther2003，25，： | 1 |
| 20 | The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics显示文摘 | Martin PD Schneck DW Dane AL | 2008 | Curr Med Res Opin2008，24，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员